Médecins Sans Frontières (MSF) has announced plans to treat 30,000 Rohingya refugees for Hepatitis C by 2026. Since October 2020, MSF has already provided treatment to over 10,000 patients at its hospitals in Jamtoli and Pahari. A 2023 study found that one in five adults in the refugee camps is infected with the virus, underscoring the urgent need for expanded medical intervention.